financetom
Business
financetom
/
Business
/
Microsoft's Activision Owes $23.4 Million for Patent Infringement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microsoft's Activision Owes $23.4 Million for Patent Infringement
May 6, 2024 10:45 AM

01:19 PM EDT, 05/06/2024 (MT Newswires) -- Microsoft's ( MSFT ) Activision must pay Acceleration LLC $23.4 million after a federal jury in Delaware found that it infringed claim 12 of US Patent No. 6.701,344 for which it owes $18 million and claim 1 of US Patent No. 6,731.147 for which it owes $5.4 million.

Activision is also found to be liable to the plaintiff for prejudgment interest in an amount to be calculated.

Price: 409.93, Change: +3.27, Percent Change: +0.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Profound Medical Receives FDA Approval for AI-Powered Prostate Disease Device --Shares Advance Pre-Bell
Profound Medical Receives FDA Approval for AI-Powered Prostate Disease Device --Shares Advance Pre-Bell
May 14, 2024
08:30 AM EDT, 05/14/2024 (MT Newswires) -- Profound Medical ( PROF ) said Tuesday that it received US Food and Drug Administration clearance for its TULSA-AI Contouring Assistant for use with its TULSA-PRO system to treat prostate disease. The medical device company said that TULSA uses pixel-by-pixel precision and sound technology to kill diseased prostate tissue without damaging urinary or...
Profound Medical Receives U.S. FDA  Clearance for
Profound Medical Receives U.S. FDA Clearance for "Contouring Assistant" AI Module
May 14, 2024
08:18 AM EDT, 05/14/2024 (MT Newswires) -- Profound Medical ( PROF ) said on Tuesday that it received 510(k) clearance from the Food and Drug Administration for the company's second TULSA-AI module, Contouring Assistant, for use with its TULSA-PRO system. Contouring Assistant is a machine learning-based prostate segmentation tool designed to assist in delineating the prostate and target ablation volume....
POET Technologies to Collaborate with Foxconn Interconnect Technology for High-Speed AI Systems
POET Technologies to Collaborate with Foxconn Interconnect Technology for High-Speed AI Systems
May 14, 2024
08:28 AM EDT, 05/14/2024 (MT Newswires) -- POET Technologies ( POET ) said Tuesday that it agreed to collaborate with Foxconn Interconnect Technology (FIT) to develop 800G and 1.6T pluggable optical transceiver modules using POET's optical engines. The company's share price jumped 8.3% to US$2.36 at last look in US pre-market trading. The partnership aims to address growing demand from...
PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application
PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application
May 14, 2024
08:26 AM EDT, 05/14/2024 (MT Newswires) -- PTC Therapeutics ( PTCT ) said Tuesday the US Food and Drug Administration granted priority review for its biologics license application for gene therapy Upstaza. The application was given a target regulatory action date of Nov. 13, PTC said. Upstaza is a one-time gene replacement therapy for aromatic L-amino acid decarboxylase, or AADC,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved